Pine Pharmaceuticals of Tonawanda confirmed Thursday that it will lay off 58 employees, or about 25% of its workforce, due to ...

HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral ...

Wave Life Sciences' WVE-006 study shows significant promise in treating alpha-1 antitrypsin deficiency. Learn more about WVE ...

The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.

Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on ...

There is no simple solution to tackling health inequity, but we’re confident that infusing health equity principles across ...

Earlier this year, Evonik unveiled a restructuring project that will result in up to 2,000 layoffs. | After Evonik in March ...

Timing Trades in Takeda Pharmaceutical Company Limited American Depositary Shares (each Representing 1/2 Of A Share Of) TAK ...

More than 15.5 million U.S. adults have been diagnosed with ADHD, and nearly three-quarters of those taking medication to ...

Several major companies have either recently dropped their DEI efforts or publicly distanced themselves from those ...